SCHEMBL3597267

SCHEMBL3597267

CN(CCNC(=O)Cn1cnc2cccnc21)C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.41
ACHE P22303 3/20 0.41
TP53 P04637 3/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 2/20 0.39
GAA P10253 1/20 0.39
GLA P06280 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
PABPC1 P11940 1/20 0.39
POLB P06746 1/20 0.39
CXCR3 P49682 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605621 0.84 TRPA1 (0.43) BCHEACHETP53MAPTTSHR
SCHEMBL3597269 0.81 ENPP2 (0.45) TP53TSHRMAPK1MEN1KMT2A
SCHEMBL3602186 0.79 TP53 (0.41) TP53MAPTTSHRGAAMAPK1
SCHEMBL5345349 0.79 TRPA1 (0.43) TP53MAPTTSHRGAAMAPK1
SCHEMBL3597098 0.78 KMT2A (0.42) TP53MAPTMAPK1MEN1KMT2A
SCHEMBL13115367 0.78 TRPA1 (0.42) TP53MAPTTSHRGAAMAPK1
SCHEMBL13115365 0.78 TRPV1 (0.46) BCHEACHETP53MAPTTSHR
SCHEMBL3605821 0.78 CCNE1 (0.43) BCHEACHETP53MAPTTSHR
SCHEMBL3591241 0.78 CHEK1 (0.41) BCHEACHETP53MAPTTSHR
SCHEMBL3606205 0.77 TP53 (0.45) TP53MAPTMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 BCHE 2360/4885ACHE 4160/4885TP53 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.